PSYCH up2date, Inhaltsverzeichnis PSYCH up2date 2014; 8(01): 21-36DOI: 10.1055/s-0033-1359955 Angststörungen, Zwangsstörungen und stressassoziierte Störungen Störungsspezifische Therapie der Zwangsstörungen Authors Ulrich Voderholzer Maike Müller Anne Katrin Külz Artikel empfehlen Abstract Artikel einzeln kaufen(opens in new window) Alle Artikel dieser Rubrik(opens in new window) Volltext Referenzen Literatur 1 Wittchen HU, Jacobi C. DEGS Studie zur Gesundheit Erwachsener in Deutschland: Was sind die häufigsten psychischen Störungen in Deutschland?. Berlin: Robert Koch-Institut; 2012 2 Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Archives of General Psychiatry 1999; 56: 121-127 3 Voderholzer U, Hohagen F. Therapie psychischer Erkrankungen: State of the Art 2010/2011. 6. Aufl. München: Urban & Fischer, Elsevier; 2011: 414-415 4 Förstner U, Külz AK, Voderholzer U. Störungsspezifische Behandlung der Zwangsstörungen: Ein Therapiemanual. Stuttgart: Kohlhammer; 2011 5 Olatunji BO, Davis ML, Powers MB. et al. Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators. J Psychiatric Res 2013; 47: 33-41 6 Soomro GM, Altman D, Rajagopal S. et al. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008; 1: CD001765 7 Karno M, Golding JM, Sorenson SB. et al. The epidemiology of obsessive-compulsive disorder in five US communities. Arch General Psychiatry 1988; 45: 1094-1099 8 Hertenstein E, Thiel N, Herbst N. et al. Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: a study with 12 months follow-up. Ann Gen Psychiatry 2013; 12: 4 9 WHO. Dilling H, Mombour W, Schmidt MH. Hrsg. Internationale Klassifikation psychischer Störungen. Vol. 4. Bern: Verlag Hans Huber; 2000 10 Goodman WK, Price LH, Rasmussen SA. et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry 1989; 46: 1006-1011 11 Abramowitz JS, Deacon BJ. Psychometric properties and construct validity of the Obsessive-Compulsive Inventory-Revised: Replication and extension with a clinical sample. J Anxiety Disorders 2006; 20: 1016-1035 12 Jacobsen D, Kloss M, Fricke S. et al. Reliabilität der deutschen Version der Yale-Brown Obsessive Compulsive Scale. Verhaltenstherapie 2003; 13: 111-113 13 Nestadt G, Bienvenu OJ, Cai G. et al. Incidence of obsessive-compulsive disorder in adults. J Nerv Ment Dis 1998; 186: 401-406 14 Voderholzer U, Riemann D, Huwig-Poppe C. et al. Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency. Eur Arch Psychiatry Clin Neurosci 2007; 257: 173-182 15 Thiel N, Hertenstein E, Nissen C. et al. The effect of personality disorders on treatment outcomes in patients with obsessive-compulsive disorders. J Personality Disorders 2013; 27: 697-715 16 Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs. Br J Psychiatry 1998; 173 (Suppl. 35) 7-12 17 Grabe HJ, Ruhrmann S, Ettelt S. et al. Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects. Am J Psychiatry 2006; 163: 1986-1992 18 Schirmbeck F, Esslinger C, Rausch F. et al. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychological Med 2011; 41: 2361-2373 19 Maier S, Kuelz AK, Voderholzer U. Traumatisierung und Dissoziationsneigung bei Zwangserkrankten: Ein Überblick. Verhaltenstherapie 2009; 19: 219-227 20 Obsessive Compulsive Cognitions Working Group (OCCWG). Cognitive assessment of obsessive-compulsive disorder. Behav Res Ther 1997; 35: 667-681 21 Kuelz AK, Voderholzer U. [Psychotherapy for obsessive-compulsive disorder: what is evidence based?. ] Nervenarzt 2011; 82: 308-310,312,314-316 22 Walitza S, Melfsen S, Jans T. et al. Zwangsstörung im Kindes- und Jugendalter. Dtsch Arztebl International 2011; 108: 173-179 23 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Kordon A. et al. S3 Leitlinie Zwangsstörungen. Zugriff am 18. Dezember 2013 unter: http://www.awmf.org/uploads/tx_szleitlinien/038_017l_S3_Zwangsstörungen_2013.pdf 24 Lakatos A, Reinecker H. Kognitive Verhaltenstherapie bei Zwangsstörungen. Ein Therapiemanual. 3. Aufl. Göttingen: Hogrefe; 2007 25 Foa EB, Liebowitz MR, Kozak MJ. et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 151-161 26 Jaurrieta N, Jiménez-Murcia S, Alonso P. et al. Individual versus group cognitive behavioral treatment for obsessive-compulsive disorder: Follow up. Psychiatry Clin Neurosci 2008; 62: 697-704 27 Cottraux J, Mollard E, Bouvard M. et al. Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One-year followup. Psychiatry Res 1993; 49: 63-75 28 Salkovskis PM. Understanding and treating obsessive-compulsive disorder. Behaviour Res Ther 1999; 37 (Suppl. 01) S29-S52 29 Kulz AK, Rose N. [Mindfulness Based Cognitive Therapy (MBCT) in patients with obsessive-compulsive disorder – an adaptation of the original program]. Psychother Psychosom Med Psychol 2013; (in press) 0 30 Twohig MP, Hayes SC, Plumb JC. et al. A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. J Consult ClinPsychol 2010; 78: 705-716 31 Piccinelli M, Pini S, Bellantuono C. et al. Efficacy of drug treatment in obsessive-compulsive disorder: A meta-analytic review. Br J Psychiatry 1995; 166: 424-443 32 Phelps NJ, Cates ME. The role of venlafaxine in the treatment of obsessive-compulsive disorder. Ann Pharmacotherapy 2005; 39: 136-140 33 Koran LM, Hanna GL, Hollander E. et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007; 164: 5-53 34 Ninan PT, Koran LM, Kiev A. et al. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. J Clin Psychiatry 2006; 67: 15-22 35 Kordon A, Kahl KG, Broocks A. et al. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 2005; 255: 48-50 36 Greenberg BD, Gabriels LA, Malone Jr DA. et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry 2010; 15: 64-79 37 Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia – Clinical characteristics and treatment. Cns Drugs 2004; 18: 989-1010 38 Freeman JB, Choate-Summers ML, Moore PS. et al. Cognitive behavioral treatment for young children with obsessive-compulsive disorder. Biol Psychiatry 2007; 61: 337-343 39 Dtsch Gesellschaft für Kinder- und Jugendpsychiatrie. Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Köln: Deutscher Ärzte Verlag; 2007
